welcome to DuchenneXchange

- a positively charged Duchenne muscular dystrophy community.
  • join today!

Jerry R. Mendell, MD

Principal Investigator
Center for Gene Therapy
The Research Institute
Nationwide Children's Hospital
700 Childrens Drive
Columbus, Ohio, United States

Jerry R. Mendell, MD, is an attending neurologist at Nationwide Children’s, principal investigator in the Center for Gene Therapy at The Research Institute of Nationwide Children’s, Director of the Paul D. Wellstone Muscular Dystrophy Cooperative Research Center, Co-director of the Muscular Dystrophy Association Clinic, and Professor of Pediatrics, Neurology, Pathology, and Physiology and Cell Biology at The Ohio State University College of Medicine. Dr. Mendell was among the first to test muscle cell transplantation for Duchenne muscular dystrophy in the early 1990’s and the first person to study viral mediated gene therapy for muscular dystrophy in humans.

His Lab is devoted to the development of potential treatments for neuromuscular diseases including Duchenne muscular dystrophy (DMD) and limb-girdle muscular dystrophy (LGMD). The Mendell lab also serves as the diagnostic lab of muscle biopsies for the Anatomic Pathology Department of Nationwide Children’s Hospital.


Representative Publications:

AAV-mediated Overexpression of Human a7 Integrin Leads to Histological and Functional Improvement in Dystrophic Mice

Update on the treatment of Duchenne muscular dystrophy

LTBP4 genotype predicts age of ambulatory loss in duchenne muscular dystrophy

Precordial R Wave Height Does Not Correlate with Echocardiographic Findings in Boys with Duchenne Muscular Dystrophy

Report of MDA muscle disease symposium on newborn screening for Duchenne muscular dystrophy